Cannabis Suisse Corp. Stock

Equities

CSUI

US13767A1034

Pharmaceuticals

Market Closed - OTC Markets 15:01:06 2024-05-03 EDT 5-day change 1st Jan Change
0.015 USD -1.32% Intraday chart for Cannabis Suisse Corp. -42.31% -45.26%
Sales 2022 7.77K 10.63K Sales 2023 10K 13.68K Capitalization 3.5M 4.78M
Net income 2022 - 0 Net income 2023 - 0 EV / Sales 2022 114 x
Net Debt 2022 137K 187K Net Debt 2023 477K 652K EV / Sales 2023 397 x
P/E ratio 2022
-3.26 x
P/E ratio 2023
-9.45 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 73.19%
More Fundamentals * Assessed data
Dynamic Chart
Cannabis Suisse Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 CI
Cannabis Suisse Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023 CI
Cannabis Suisse Corp. Reports Earnings Results for the First Quarter Ended August 31, 2023 CI
Cannabis Suisse Corp. Reports Earnings Results for the Full Year Ended May 31, 2023 CI
Cannabis Suisse Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2023 CI
Cannabis Suisse Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2022 CI
Cannabis Suisse Corp. Reports Earnings Results for the First Quarter Ended August 31, 2022 CI
Cannabis Suisse Corp. Reports Earnings Results for the Full Year Ended May 31, 2022 CI
Cannabis Suisse Corp. Auditor Raises 'Going Concern' Doubt CI
Cannabis Suisse Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022 CI
Cannabis Suisse Corp. Announces Management Changes CI
Cannabis Suisse Corp. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2021 CI
Cannabis Suisse Corp. Reports Earnings Results for the First Quarter Ended August 31, 2021 CI
Cannabis Suisse Corp. Reports Earnings Results for the Full Year Ended May 31, 2021 CI
Cannabis Suisse Corp. Reports Earnings Results for the Third Quarter Ended February 28, 2021 CI
More news
1 day-1.32%
1 week-42.31%
Current month-1.32%
1 month-3.85%
3 months-46.24%
6 months-28.57%
Current year-45.26%
More quotes
1 week
0.02
Extreme 0.015
0.02
1 month
0.01
Extreme 0.012
0.03
Current year
0.00
Extreme 0.0012
0.03
1 year
0.00
Extreme 0.0012
0.08
3 years
0.00
Extreme 0.0012
0.30
5 years
0.00
Extreme 0
2.25
10 years
0.00
Extreme 0
2.25
More quotes
Managers TitleAgeSince
Chief Executive Officer 43 22-05-23
Chief Operating Officer 35 22-01-18
Members of the board TitleAgeSince
Chief Operating Officer 35 22-01-18
Chief Executive Officer 43 22-05-23
More insiders
Date Price Change Volume
24-05-03 0.015 -1.32% 31,733
24-04-30 0.0152 -41.54% 1,233
24-04-26 0.026 +8.33% 57,050
24-04-25 0.024 +100.00% 1,000

Delayed Quote OTC Markets, May 03, 2024 at 03:01 pm

More quotes
Cannabis Suisse Corp. is engaged in the business of production of over the counter (OTC) products, such as cannabidiol (CBD) oils, retail branded cigarettes and also some health-related supplements. The Company's products include Flavored Broad-Spectrum CBD Oils and CBD Isolate Tinctures with no tetrahydrocannabinol (THC). Flavored Broad-Spectrum CBD Oils products come in one fluid ounce (30 milliliters (ml)) bottles available in two flavors, such as Creme de Menthe and Cherry Vanilla. Its available CBD concentrations are 1500 milligrams (mg), 2500 mg and 3500 mg. CBD Isolate Tinctures with no THC products come in one fluid ounce (30 ml) bottles with 1000 mg CBD concentrations per bottle and 33.33 mg CBD per serving. CBD Tinctures are designed to have therapeutic effects.
More about the company